- Investing Ideas
- Software Healthcare Sector
Software Healthcare Sector
Results
2168
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2168 companies
PetVivo Holdings
Market Cap: US$26.5m
A biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States.
PETV
US$0.68
7D
0.4%
1Y
-15.0%
Enlivex
Market Cap: US$26.4m
Operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel.
ENLV
US$1.52
7D
0%
1Y
-90.6%
Atossa Therapeutics
Market Cap: US$26.3m
A clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States.
ATOS
US$2.68
7D
3.5%
1Y
-77.0%
Onco-Innovations
Market Cap: CA$36.2m
A pre-clinical stage biotechnology company, develops drug candidates for cancer treatments in Canada.
ONCO
CA$0.54
7D
-8.5%
1Y
-71.6%
Beamtree Holdings
Market Cap: AU$36.3m
Provides artificial intelligence-based decision support software and data insight solutions, and other software services to the healthcare industry in Australia and internationally.
BMT
AU$0.13
7D
25.0%
1Y
-53.7%
Emyria
Market Cap: AU$36.3m
Engages in delivering and developing of treatments for mental health and select neurological conditions in Australia.
EMD
AU$0.045
7D
-4.3%
1Y
-15.1%
GridAI Technologies
Market Cap: US$25.8m
Designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources.
GRDX
US$4.06
7D
4.4%
1Y
n/a
Thiogenesis Therapeutics
Market Cap: CA$35.7m
A clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs.
TTI
CA$0.51
7D
-7.3%
1Y
-35.4%
OncoSil Medical
Market Cap: AU$36.0m
A medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma.
OSL
AU$1.17
7D
1.3%
1Y
6.9%
Third Age Health Services
Market Cap: NZ$43.1m
Provides general practice health care services for older people living in retirement villages, private hospitals, and secure dementia units in New Zealand.
TAH
NZ$4.33
7D
-9.6%
1Y
-0.2%
Elite Health Systems
Market Cap: US$25.7m
Through its subsidiaries, develops a business to provide Medicare Advantage plans and other healthcare related services in California and Nevada.
EHSI
US$0.90
7D
0%
1Y
-34.8%
Renalytix
Market Cap: UK£18.8m
Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States.
RENX
UK£0.043
7D
8.9%
1Y
-25.2%
Imugene
Market Cap: AU$35.7m
A clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia.
IMU
AU$0.073
7D
-11.0%
1Y
-71.9%
EOM Pharmaceuticals Holdings
Market Cap: US$25.3m
A clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States.
IMUC
US$0.20
7D
42.9%
1Y
108.6%
Provectus Biopharmaceuticals
Market Cap: US$25.2m
A clinical-stage biotechnology company, engages in developing immunotherapy medicines for various diseases in the United States.
PVCT
US$0.06
7D
5.4%
1Y
-33.0%
Marker Therapeutics
Market Cap: US$25.0m
A clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States.
MRKR
US$1.52
7D
32.2%
1Y
52.0%
Femasys
Market Cap: US$25.0m
A biomedical company, develops and commercializes therapeutic and diagnostic products for women’s reproductive health needs in the United States and internationally.
FEMY
US$2.85
7D
29.5%
1Y
-62.1%
Clever Culture Systems
Market Cap: AU$34.9m
Engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, China, Netherlands, and Germany.
CC5
AU$0.016
7D
14.3%
1Y
-54.3%
Global Innovative Platforms
Market Cap: US$24.9m
Engages in the business of testing breath to detect and assist in the treatment of disease.
GIPL
US$0.50
7D
11.7%
1Y
n/a
Aytu BioPharma
Market Cap: US$24.8m
A pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally.
AYTU
US$2.35
7D
-0.4%
1Y
3.1%
Dyadic International
Market Cap: US$24.8m
A biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States.
DYAI
US$0.69
7D
-9.6%
1Y
-23.6%
Barinthus Biotherapeutics
Market Cap: US$24.6m
Engages in the research, development, and commercialization of immunotherapies and vaccines in the United States and the United Kingdom.
BRNS
US$0.66
7D
6.5%
1Y
-44.5%
CEL-SCI
Market Cap: US$24.3m
A clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States.
CVM
US$1.48
7D
-6.9%
1Y
-86.9%
Guided Therapeutics
Market Cap: US$24.1m
A medical technology company, researches, develops, tests, manufactures, sells, and distributes medical devices in the United States and internationally.
GTHP
US$0.25
7D
0.4%
1Y
-10.7%
Jasper Therapeutics
Market Cap: US$24.0m
A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States.
JSPR
US$0.72
7D
-4.0%
1Y
-75.3%
TherapeuticsMD
Market Cap: US$24.0m
Operates as a pharmaceutical royalty company in the United States and internationally.
TXMD
US$2.28
7D
13.4%
1Y
103.4%
Cellectar Biosciences
Market Cap: US$23.8m
A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.
CLRB
US$2.54
7D
-1.9%
1Y
-46.6%
BioXcel Therapeutics
Market Cap: US$23.8m
Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.
BTAI
US$0.74
7D
-6.3%
1Y
-85.8%
Tvardi Therapeutics
Market Cap: US$23.7m
A clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States.
TVRD
US$1.82
7D
-4.2%
1Y
-93.8%
RUA Life Sciences
Market Cap: UK£17.4m
Develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa.
RUA
UK£0.28
7D
7.7%
1Y
130.9%
Resverlogix
Market Cap: CA$32.7m
A late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses.
RVX
CA$0.10
7D
5.0%
1Y
2.4%
Promisia Healthcare
Market Cap: NZ$39.6m
Engages in the aged care and retirement living business in New Zealand.
PHL
NZ$0.75
7D
5.6%
1Y
74.4%
Niki BioSolutions
Market Cap: US$23.5m
Through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases.
NIKI
US$7.91
7D
-1.1%
1Y
216.2%
NeuPath Health
Market Cap: CA$32.5m
Provides chronic pain management services in Canada.
NPTH
CA$0.56
7D
-6.7%
1Y
86.7%
Vitasora Health
Market Cap: AU$32.8m
Researches, develops, and commercializes medical devices in Australia and the United States.
VHL
AU$0.014
7D
0%
1Y
-51.7%
Cytosorbents
Market Cap: US$23.3m
Engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally.
CTSO
US$0.36
7D
-1.3%
1Y
-61.8%